Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 07, 2020
CATO SMS has unveiled its new brand, revealing an updated look and logo capturing the company’s offering following the merger of CATO Research, and Specialized Medical Services-oncology.
read more
Wednesday, October 24, 2018
CavoGene has licensed a novel investigational gene therapy for patients with neurodegenerative diseases.
read more
Monday, November 23, 2020
CCRM and MIP have signed a LOI to partner in the development of a biomanufacturing campus at MIP focused on regenerative medicine-based technologies and cell and gene therapies.
read more
CCRM and its CDMO subsidiary OmniaBio announced an agreement with Avectas Limited to evaluate its automated, integrated and scalable cell therapy manufacturing platform.
read more
CDI Labs Canada Inc., a provider of services for proteome-wide antibody profiling and target identification, announced the launch of its Technology Access Program for custom peptide libraries for serum antibody analysis services.
read more
Thursday, September 21, 2023
The Montreal-based CDMO C3i Center Inc is paving the way in the cell and gene therapy industry in North American and Canada as one of a few contract development and manufacturing organizations (CDMOs) to be producing in North America and for Europe. ...
read more
eXmoor Pharma and Evox Therapeutics have completed a technology transfer program for Evox’s exosome-enabled gene editing platform, including its MSH3-targeted program for Huntington’s disease, at eXmoor’s Bristol, UK facility.
read more
Spray drying and capsule filling service provider Micro-Sphere is investing €19 million into expanding its GMP manufacturing capabilities at its facility in Switzerland.
read more
The Wasdell Group has secured a new contract to supply medicines and dietary supplements directly to consumers from its Swindon, UK, site.
read more
Tuesday, February 18, 2014
Cedarburg Hauser Pharmaceuticals (CHP), an experienced contract
development and manufacturing organization (CDMO) specializing in small molecule APIs, has
announced the hire Alex Tretyakov, Ph.D. as its Director of Process Development.
read more
Thursday, November 08, 2012
Cedarburg Hauser Pharmaceuticals (CHP), an experienced contract development and manufacturing organization (CDMO), has announced the appointment of John K. Lynch, Ph.D. as its Chief Scientific Officer (CSO).
read more
CEL-SCI has signed a collaboration agreement with the University of Georgia’s Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy.
read more
Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has announced the acquisition of Qdossier, a supplier of end-to-end services to support document and dossier lifecycle management for ...
read more
Thursday, August 03, 2023
Celegence, a regulatory compliance service and software solution company, announced the launch of CAPTIS Copilot, the most advanced document automation and literature review solution for the life sciences industry.
read more
Tuesday, February 06, 2024
Celerion, a clinical research organization, announced its recent achievement of obtaining the Clinical Laboratory Improvement Amendments (CLIA) certification for its state-of-the-art bioanalytical laboratory located in Lincoln, Nebraska.
read more